Arena Pharmaceuticals, Inc. (ARNA) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
6154 NANCY RIDGE DRIVE SAN DIEGO, CA 92121 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 1,104,041 | 739,565 | 445,631 | 271,300 | 90,712 | 156,184 | |||
| Cash and cash equivalents | 219,544 | 243,274 | 161,037 | 158,837 | 90,712 | 156,184 | |||
| Short-term investments | 884,497 | 496,291 | 284,594 | 88,240 | |||||
| Other undisclosed cash, cash equivalents, and short-term investments | 24,223 | ||||||||
| Receivables | 1,654 | 5,086 | 2,357 | 20,162 | 4,934 | ||||
| Inventory, net of allowances, customer advances and progress billings | 6,708 | 9,502 | |||||||
| Inventory | 6,708 | 9,502 | |||||||
| Contract with customer, asset, after allowance for credit loss | 1,484 | ✕ | ✕ | ✕ | |||||
| Disposal group, including discontinued operation | 17,140 | ||||||||
| Other undisclosed current assets | 35,266 | 18,715 | 8,524 | (9,517) | 2,307 | 4,218 | |||
| Total current assets: | 1,139,307 | 759,934 | 460,725 | 281,280 | 119,889 | 174,838 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 22,090 | 25,128 | 23,114 | 30,131 | 43,828 | 71,828 | |||
| Long-term investments and receivables | 370,938 | 82,412 | 24,242 | ||||||
| Long-term investments | 370,938 | 82,412 | 24,242 | ||||||
| Intangible assets, net (including goodwill) | 2,357 | 7,775 | |||||||
| Intangible assets, net (excluding goodwill) | 2,357 | 7,775 | |||||||
| Disposal group, including discontinued operation, noncurrent assets | 1,233 | ||||||||
| Other noncurrent assets | 29,323 | 18,123 | 10,319 | 3,622 | 2,936 | 2,351 | |||
| Deferred tax assets, net | ✕ | ✕ | ✕ | 110,333 | |||||
| Other undisclosed noncurrent assets | (1,233) | ||||||||
| Total noncurrent assets: | 51,413 | 414,189 | 226,178 | 57,995 | 49,121 | 81,954 | |||
| TOTAL ASSETS: | 1,190,720 | 1,174,123 | 686,903 | 339,275 | 169,010 | 256,792 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 35,351 | 25,499 | 16,181 | 7,916 | 12,054 | 8,334 | |||
| Employee-related liabilities | 18,846 | 14,329 | 8,622 | 5,255 | 4,820 | 5,118 | |||
| Accounts payable | 12,004 | 6,043 | 6,192 | 1,599 | 5,977 | 2,078 | |||
| Accrued liabilities | 4,501 | 5,127 | 1,367 | 1,062 | 1,257 | 1,138 | |||
| Restructuring reserve | 62 | ||||||||
| Estimated litigation liability | 24,000 | ||||||||
| Disposal group, including discontinued operation | 27,595 | ||||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 1,110 | 35,288 | 21,425 | ||
| Other undisclosed current liabilities | 22,726 | 19,468 | 13,737 | 11,706 | 16,475 | 20,137 | |||
| Total current liabilities: | 58,077 | 44,967 | 29,918 | 72,327 | 63,879 | 49,896 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | |||||||||
| Liabilities, other than long-term debt | 10,963 | 12,078 | 1,301 | 2,056 | 2,988 | 88,087 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 1,067 | 2,167 | 88,087 | ||
| Other liabilities | 10,963 | 12,078 | 1,301 | 989 | 821 | ||||
| Operating lease, liability | ✕ | ✕ | ✕ | ✕ | |||||
| Other undisclosed noncurrent liabilities | 41,211 | 45,613 | 49,426 | 57,748 | 61,748 | ||||
| Total noncurrent liabilities: | 52,174 | 57,691 | 50,727 | 59,804 | 64,736 | 88,087 | |||
| Total liabilities: | 110,251 | 102,658 | 80,645 | 132,131 | 128,615 | 137,983 | |||
| Equity | |||||||||
| Equity, attributable to parent | 1,080,469 | 1,071,465 | 606,258 | 207,144 | 39,904 | 53,542 | |||
| Common stock | 6 | 5 | 5 | 4 | 24 | 24 | |||
| Additional paid in capital | 2,587,494 | 2,173,154 | 2,106,960 | 1,698,543 | 1,441,715 | 1,430,917 | |||
| Accumulated other comprehensive income (loss) | 700 | 1,303 | (155) | (1,216) | (3,099) | (1,179) | |||
| Accumulated deficit | (1,507,731) | (1,102,997) | (1,500,552) | (1,490,187) | (1,398,736) | (1,376,220) | |||
| Equity, attributable to noncontrolling interest | 491 | ||||||||
| Total equity: | 1,080,469 | 1,071,465 | 606,258 | 207,144 | 40,395 | 53,542 | |||
| Other undisclosed liabilities and equity | 65,267 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 1,190,720 | 1,174,123 | 686,903 | 339,275 | 169,010 | 256,792 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 319 | 806,431 | 17,970 | 21,337 | 123,975 | 38,326 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 1,705 | 6,700 | 19,726 | |
| Sublease income | ✕ | ✕ | ✕ | ✕ | ||||
| Cost of revenue | (14,461) | (791) | (379) | (13,860) | (15,902) | |||
| Cost of goods and services sold | (9,297) | (8,590) | ||||||
| Gross profit: | 319 | 791,970 | 17,179 | 20,958 | 110,115 | 22,424 | ||
| Operating expenses | (426,958) | (309,224) | (161,962) | (112,925) | (127,261) | (125,622) | ||
| Other undisclosed operating loss | ||||||||
| Operating income (loss): | (426,639) | 482,746 | (144,783) | (91,967) | (17,146) | (103,198) | ||
| Nonoperating income (expense) | 21,905 | 25,142 | 5,949 | (3,887) | (5,750) | (4,781) | ||
| Investment income, nonoperating | 24,007 | 26,872 | 8,772 | 492 | 290 | 158 | ||
| Other nonoperating income (expense) | 2,421 | 3,061 | 2,872 | 1,740 | 472 | 1,415 | ||
| Interest and debt expense | (4,523) | (4,791) | (5,695) | (6,119) | (6,512) | (6,828) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 6,892 | 6,828 | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (409,257) | 503,097 | (144,529) | (101,973) | (22,516) | (107,979) | ||
| Other undisclosed income from continuing operations before income taxes | 4,523 | 4,791 | 5,695 | |||||
| Income (loss) from continuing operations before income taxes: | (404,734) | 507,888 | (138,834) | (101,973) | (22,516) | (107,979) | ||
| Income tax expense (benefit) | (110,333) | 110,265 | ||||||
| Other undisclosed income from continuing operations | 6,119 | |||||||
| Income (loss) from continuing operations: | (404,734) | 397,555 | (28,569) | (95,854) | (22,516) | (107,979) | ||
| Income (loss) before gain (loss) on sale of properties: | (404,734) | 397,555 | (29,399) | (92,732) | (22,516) | (107,979) | ||
| Income (loss) from discontinued operations | (830) | 3,122 | ||||||
| Other undisclosed net loss | (380) | |||||||
| Net income (loss): | (404,734) | 397,555 | (29,399) | (92,732) | (22,896) | (107,979) | ||
| Net income attributable to noncontrolling interest | 1,325 | 380 | ||||||
| Net income (loss) available to common stockholders, diluted: | (404,734) | 397,555 | (29,399) | (91,407) | (22,516) | (107,979) | ||
Comprehensive Income ($ in thousands)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (404,734) | 397,555 | (29,399) | (92,732) | (22,896) | (107,979) | ||
| Other comprehensive income (loss) | (764) | 1,469 | (113) | |||||
| Other undisclosed comprehensive income (loss) | (11) | 72 | 1,883 | (1,920) | ||||
| Comprehensive income (loss): | (405,498) | 399,013 | (29,440) | (90,849) | (24,816) | (107,979) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 1,325 | 380 | ||||||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 161 | (4,087) | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (405,337) | 399,013 | (29,440) | (89,524) | (24,436) | (112,066) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.